Risk of solid cancer in low dose-rate radiation epidemiological studies and the dose-rate effectiveness factor
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Purpose: Estimated radiation risks used for radiation protection purposes have been based primarily on the Life Span Study (LSS) of atomic bomb survivors who received brief exposures at high dose rates, many with high doses. Information is needed regarding radiation risks from low dose-rate (LDR) exposures to low linear-energy-transfer (low-LET) radiation. We conducted a meta-analysis of LDR epidemiologic studies that provide dose-response estimates of total solid cancer risk in adulthood in comparison to corresponding LSS risks, in order to estimate a dose rate effectiveness factor (DREF).Materials and methods: We identified 22 LDR studies with dose-response risk estimates for solid cancer after minimizing information overlap. For each study, a parallel risk estimate was derived from the LSS risk model using matching values for sex, mean ages at first exposure and attained age, targeted cancer types, and accounting for type of dosimetric assessment. For each LDR study, a ratio of the excess relative risk per Gy (ERR Gy−1) to the matching LSS ERR risk estimate (LDR/LSS) was calculated, and a meta-analysis of the risk ratios was conducted. The reciprocal of the resultant risk ratio provided an estimate of the DREF.Results: The meta-analysis showed a LDR/LSS risk ratio of 0.36 (95% confidence interval [CI] 0.14, 0.57) for the 19 studies of solid cancer mortality and 0.33 (95% CI 0.13, 0.54) when three cohorts with only incidence data also were added, implying a DREF with values around 3, but statistically compatible with 2. However, the analyses were highly dominated by the Mayak worker study. When the Mayak study was excluded the LDR/LSS risk ratios increased: 1.12 (95% CI 0.40, 1.84) for mortality and 0.54 (95% CI 0.09, 0.99) for mortality + incidence, implying a lower DREF in the range of 1–2. Meta-analyses that included only cohorts in which the mean dose was <100 mGy yielded a risk ratio of 1.06 (95% CI 0.30, 1.83) for solid cancer mortality and 0.58 (95% CI 0.10, 1.06) for mortality + incidence data.Conclusions: The interpretation of a best estimate for a value of the DREF depends on the appropriateness of including the Mayak study. This study indicates a range of uncertainty in the value of DREF between 1 and about 2 after protracted radiation exposure. The LDR data provide direct evidence regarding risk from exposures at low dose rates as an important complement to the LSS risk estimates used for radiation protection purposes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709 · cited 1×
“If studies with small or negative risks remain unpublished, this could result in publication bias indicated by asymmetric funnel plots (Sterne & Egger 2001; Sterne et al. 2011).”
BackgroundFunnel plots for detecting bias in meta-analysis
Sterne, J. A. C., & Egger, M. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00377-8 · Cited by 3,779
A Nonparametric “Trim and Fill” Method of Accounting for Publication Bias in Meta-Analysis
Duval, S., & Tweedie, R. (2000) · Journal of the American Statistical Association · doi:10.1080/01621459.2000.10473905 · Cited by 2,955 · cited 6×
“1997) to detect funnel plot asymmetry by testing whether the observed outcomes are related to their corresponding sampling variances; and the trim and fill method that applies a nonparametric (rank-based) data augmentation technique to estimate how many negative studies may be missing and their potential impact on the…”
BackgroundMethodInfluentialMeta-analysis in clinical trials revisited
DerSimonian, R., & Laird, N. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.09.002 · Cited by 2,677
Random-effects model for meta-analysis of clinical trials: An update
DerSimonian, R., & Kacker, R. (2007) · Contemporary Clinical Trials · doi:10.1016/j.cct.2006.04.004 · Cited by 2,374
Random-Effects Meta-analysis of Inconsistent Effects: A Time for Change
Cornell, J. E., Mulrow, C. D., Localio, R., Stack, C. B., Meibohm, A. R., Guallar, E., & Goodman, S. N. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2886 · Cited by 453 · cited 1×
“Since methods for assessing risk heterogeneity are in flux (Cornell et al. 2014), heterogeneity also was evaluated using the several other methods described in DerSimonian & Kacker (2007).”
MethodLeuraud, K., Richardson, D. B., Cardis, E., Daniels, R. D., Gillies, M., O'Hagan, J. A., Hamra, G. B., Haylock, R., Laurier, D., Moissonnier, M., et al. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00094-0 · Cited by 442 · cited 1×
“Papers describing the cohort and dosimetry, and evaluating leukemia and solid cancer risk, have been published to date (Leuraud et al. 2015; Richardson et al. 2015; Thierry-Chef et al. 2015; Hamra et al. 2016).”
BackgroundThe Incidence of Leukemia, Lymphoma and Multiple Myeloma among Atomic Bomb Survivors: 1950–2001
Hsu, W.-L., Preston, D. L., Soda, M., Sugiyama, H., Funamoto, S., Kodama, K., Kimura, A., Kamada, N., Dohy, H., Tomonaga, M., et al. (2013) · Radiation Research · doi:10.1667/rr2892.1 · Cited by 409
Self-citation
Cited by
Projected Lifetime Cancer Risks From Current Computed Tomography Imaging
Smith-Bindman, R., Chu, P. W., Azman Firdaus, H., Stewart, C., Malekhedayat, M., Alber, S., Bolch, W. E., Mahendra, M., Berrington de González, A., & Miglioretti, D. L. (2025) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.0505 · Cited by 358
The Million Person Study relevance to space exploration and Mars
Boice, J. D. (2022) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1589020 · Cited by 34
A bespoke health risk assessment methodology for the radiation protection of astronauts
Walsh, L., Hafner, L., Straube, U., Ulanowski, A., Fogtman, A., Durante, M., Weerts, G., & Schneider, U. (2021) · Radiation and Environmental Biophysics · doi:10.1007/s00411-021-00910-0 · Cited by 23
Self-citationCancer incidence risks above and below 1 Gy for radiation protection in space
Hafner, L., Walsh, L., & Schneider, U. (2021) · Life Sciences in Space Research · doi:10.1016/j.lssr.2020.09.001 · Cited by 10
“(2009) was recently updated (Shore et al., 2017) to include 22 low-dose and/or low dose rate solid cancer studies (19 mortality studies and 3 incidence studies).”
BackgroundResultSelf-citation
Metadata
- Authors
- Shore, R., Walsh, L., Azizova, T., & Rühm, W.
- Venue
- International Journal of Radiation Biology
- Publisher
- Informa UK Limited
- Published
- 2017-05-15
- Volume
- 93
- Issue
- 10
- Pages
- 1064-1078
- ISSN
- 0955-3002 (ISSN-L)
- 1362-3095
- OpenAlex
- W2606268437
- Cited by
- 99
- References
- 8
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.